What Is Low Dose Naltrexone (LDN) and What to Expect from Treatment?
Low Dose Naltrexone (LDN) is a modified, lower-dose version of the medication naltrexone, originally developed to treat opioid and alcohol dependence. When used in much smaller doses, LDN has been found to have unique immune-modulating and anti-inflammatory properties that may benefit individuals with chronic inflammation, autoimmune conditions, or pain-related disorders.
LDN works by temporarily blocking opioid receptors, which causes the body to increase its natural production of endorphins and enkephalins—neurochemicals that help regulate immune activity, reduce inflammation, and promote an overall sense of well-being. By gently influencing these pathways, LDN supports the body’s natural balance and healing processes without the suppressive effects of traditional immune-modifying drugs.
Potential benefits of Low Dose Naltrexone may include:
- Reduced chronic inflammation and autoimmune-related flare-ups
 - Improved immune system regulation and resilience
 - Support for chronic pain management and tissue recovery
 - Enhanced energy, sleep quality, and overall mood
 - A safe, well-tolerated option for long-term immune and neurological support
 
Because LDN acts subtly and works with the body’s own regulatory systems, improvements often develop gradually over several weeks of consistent use. Its favorable safety profile and low risk of side effects make it a promising therapeutic option for those seeking natural support for immune, neurological, and inflammatory health.
    
  
  
  
  
      
      
      
      
      
      
    